Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relative bioavailability of dispersed versus whole delamanid tablets under fed conditions in healthy adults
PACTR202007578774941Phase 1Completed
- Sponsor
- Stellenbosch University
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of delamanid in Tuberculosis (TB) (3 arms), sponsored by Stellenbosch University. Primary endpoint: Relative bioavailability of dispersed versus whole delamanid tablets. Started Aug 2020; status: completed.
02
Drugs
delamanid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on PACTR202007578774941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202007578774941.